Please read and agree to the
terms and conditions
of this site.
I agree
Stream
/news
Clear filters and search
Format
photo
Tags
/business
breaking
breaking-news
business
topline
/markets
/money
aducanumab
anne white
biogen
clinical trial
donanemab
eli lilly
eli lilly and company
food and drug administration
health medical pharma
markets
money
u.s. news
us food and drug administration
What
alzheimer’s
5
×
drug
eli
5
×
fda
5
×
treatment
5
×
disease
lilly
u.s
administration
approval
called
donanemab
lilly’s
new
panel
second
trial
aduhelm
advisory
ahead
alzheimer's
approved
approves
authorized
baltimore
biogen’s
came
clinical
company
continue
decision
delay
delayed
developed
disease.the
expected
facing
federal
final
food
Language
unset
Current search:
fda
×
treatment
×
eli
×
alzheimer’s
×
{{ ::tile.facetWhoCard }}
{{ ::tile.pubDate | moment: 'fromNow'}}
Paste
[[item:{{::tile.id}}]]
to render this photo inside an other item's description.
PROCESSING
TRANSCODING
ERROR
EXTRACTING
ERROR
{{::tile.title}}